A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
PHASE2
This proof-of-concept trial is being conducted to evaluate the efficacy, sa...
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
PHASE3
This basket trial will enroll prepubertal children and adolescents with cli...
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
PHASE3
A 38-week dosing trial of lonapegsomatropin, a long-acting growth hormone p...